Clinical trial

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

NCT03759522

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2019-02-03

PhasePHASE1

Study timeline

Study start (actual)2019-02-03Date precision: day

Registry last updated2026-06-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Fibromyalgiaunresolved

Chronic Fatigue Syndromeunresolved

Multiple Sclerosisunresolved

Healthyunresolved

Interventions

DPA-714 PET/MRIDRUG

Sponsors & collaborators

University of Alabama at Birminghamlead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)collaborator

Mapped research locations

BirminghamAlabama, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03759522 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.